APA (7th ed.) Citation

Moga, E., Cantó, E., Vidal, S., Juarez, C., Sierra, J., & Briones, J. (2011). Interleukin-15 enhances rituximab-dependent cytotoxicity against chronic lymphocytic leukemia cells and overcomes transforming growth factor beta-mediated immunosuppression. Experimental hematology, 39(11), 1064-1071. https://doi.org/10.1016/j.exphem.2011.08.006

Chicago Style (17th ed.) Citation

Moga, Esther, Elisabet Cantó, Silvia Vidal, Cándido Juarez, Jorge Sierra, and Javier Briones. "Interleukin-15 Enhances Rituximab-dependent Cytotoxicity Against Chronic Lymphocytic Leukemia Cells and Overcomes Transforming Growth Factor Beta-mediated Immunosuppression." Experimental Hematology 39, no. 11 (2011): 1064-1071. https://doi.org/10.1016/j.exphem.2011.08.006.

MLA (9th ed.) Citation

Moga, Esther, et al. "Interleukin-15 Enhances Rituximab-dependent Cytotoxicity Against Chronic Lymphocytic Leukemia Cells and Overcomes Transforming Growth Factor Beta-mediated Immunosuppression." Experimental Hematology, vol. 39, no. 11, 2011, pp. 1064-1071, https://doi.org/10.1016/j.exphem.2011.08.006.